Durosinmi M A, Odebiyi A I, Akinola N O, Adediran L A, Aken'Ova Y, Okunade M A, Halim N K, Onwukeme K E, Olatunji P O, Adegoroye D E
Department of Haematology and Immunology, Obafemi Awolowo University Teaching Hospitals, Ile-Ife, Nigeria.
Afr J Med Med Sci. 1997 Mar-Jun;26(1-2):55-8.
The acceptability of prenatal diagnosis (PND) as a means of controlling sickle cell anaemia (SCA) in Nigeria was examined using a semi-structured questionnaire. The aim of the study was to examine the attitudes of well-informed, educated Nigerians to the use of PND and abortion of confirmed HbSS pregnancies in the control of SCA. There were 433 respondents comprising 204 males and 210 females (gender was not recorded for 19 respondents). They were aged 15-50 (31 +/- 18) years. Forty percent had HbAA, 15% HbAS, 1.6% HbAC, 2% HbSS, and 0.2% HbSC; 153 (35%) had no knowledge of their haemoglobin electrophoretic patterns "genotypes". The majority of the respondents (69.5%) appreciated the role of both parents in the transmission of the disease. Only 45 (18%) of the respondents heard of SCA for the first time through sickle cell counsellors, 23% through newsmedia, 29% through friends and relations, 21% obtained the information through health workers, while 5% had never heard of sickle cell disease before the interview. As many as 192 (44%) of the respondents were aware that SCA could be diagnosed in pregnancy; 45% would opt for termination of the affected pregnancies. Avoidance of the problems associated with managing SCA children was the most important reason for approving pregnancy termination, whereas 73% of those rejecting pregnancy termination did so for religious and moral reasons. Seventy-eight percent of those interviewed would want PND started in Nigeria. The two approved control measure for SCA by most of the respondents were genetic counselling and PND; both should, therefore, be considered in implementing control measures for SCA in this country.
采用半结构化问卷对尼日利亚将产前诊断(PND)作为控制镰状细胞贫血(SCA)手段的可接受性进行了调查。该研究的目的是调查了解情况且受过教育的尼日利亚人对使用产前诊断以及终止确诊为血红蛋白SS(HbSS)型妊娠以控制镰状细胞贫血的态度。共有433名受访者,其中男性204名,女性210名(19名受访者未记录性别)。他们的年龄在15至50岁之间(平均年龄31±18岁)。40%的人血红蛋白为AA型(HbAA),15%为血红蛋白AS型(HbAS),1.6%为血红蛋白AC型(HbAC),2%为血红蛋白SS型(HbSS),0.2%为血红蛋白SC型(HbSC);153人(35%)不知道自己的血红蛋白电泳模式(“基因型”)。大多数受访者(69.5%)认识到父母双方在疾病传播中的作用。只有45名(18%)受访者是通过镰状细胞病咨询人员首次听说镰状细胞贫血的,23%通过新闻媒体,29%通过朋友和亲戚,21%通过卫生工作者获得信息,而5%在访谈前从未听说过镰状细胞病。多达192名(44%)受访者知道在孕期可以诊断出镰状细胞贫血;45%的人会选择终止受影响的妊娠。避免与管理镰状细胞贫血患儿相关的问题是赞成终止妊娠的最重要原因,而73%拒绝终止妊娠的人是出于宗教和道德原因。78%的受访者希望在尼日利亚开展产前诊断。大多数受访者认可的两种控制镰状细胞贫血的措施是遗传咨询和产前诊断;因此,在该国实施镰状细胞贫血控制措施时应考虑这两项措施。